FDA warns against hand sanitizers that look like drinks
Some alcohol-based sanitizers were being sold with cartoons for children.
GOP congressional candidate Madison Cawthorn aims to be 'face' of health care reform
Madison Cawthorn, a real estate investment CEO who beat out a Trump-backed U.S. House candidate in North Carolina’s Republican primary runoff election to replace former Rep. Mark Meadows in June, told “Mornings with Maria” on Wednesday that he wants to be “the face for the Republican Party for health care reform” since he is “pretty much the principal consumer of health care in our country.”
Hospital price transparency rule still up in air as legal challenge drags on
A Trump administration rule to require additional price transparency from hospitals, which is set to take effect on Jan. 1 of next year, is still up in the air as the American Hospital Association (AHA) pursues an appeal of a lower-court decision from June that upheld the rule.
Don't argue with anti-mask customers during coronavirus, CDC warns retail employees
The government agency has advised businesses and retailers to implement procedures from mandating masks be worn by employees and customers, asking customers to follow social distancing rules and limiting the number of customers allowed inside a business at one time in order to limit the virus spread.
Frito-Lay recalls some barbecue-flavored chips over allergy concerns
All of the affected products were distributed to Arizona, California, Hawaii, Idaho, Montana, New Mexico, Nevada, Oregon, Utah, Washington and Wyoming, according to the notice.
Stop & Shop offering flu shots at over 250 locations across Northeast
With health officials urging flu vaccination this fall amid the coronavirus crisis, Stop & Shop recently announced it secured more flu vaccines as it anticipates higher demand.
Fauci warns against distributing COVID-19 vaccine under emergency guidelines before proven safe, effective
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases said there are risks in rushing out a vaccine despite the urgent need.
Google Cloud investing $100M into telehealth platform Amwell
Google Cloud is investing $100 million into telehealth provider Amwell as part of a new partnership to equip providers, insurers, patients with technology required for high quality and more affordable virtual care.
Schwarzman's Blackstone buys Japanese drugs subsidiary
Takeda Pharmaceutical Co. is selling its subsidiary in Japan focused on consumer healthcare to U.S. investment fund Blackstone Group.
Foreign agents setting up bogus election websites: DHS
With states changing voting regulations to fit stringent coronavirus guidelines, many voters will go online this year to find out how to cast their ballots for president.
New coronavirus cases below 50,000 in US for sixth straight day
New daily coronavirus cases continued to drift down from July highs this week, but deaths remained elevated, a legacy of the surge of new infections that swept the South and West last month.
NYC restaurants starved by pandemic threaten lawsuit to bring back indoor dining
A New York City Hospitality Alliance survey found that 83 percent of 471 bars and restaurants did not pay full rent in July and 37% paid no rent at all.
Coronavirus pandemic pushes expansion of 'hospital at home' treatment
Across the U.S., “hospital at home” programs are taking off amid the pandemic, thanks to communications technology, portable medical equipment and teams of doctors, nurses, X-ray techs and paramedics.
USDA ignored concerns about coronavirus on meat products and packaging, doctor group alleges in lawsuit
A pro-vegan physicians group is suing the U.S. Department of Agriculture for coronavirus warning labels on meat.
General Mills recalls mislabeled Progresso soup cans over allergen concerns
The company's recall covers less than 3,000 cans of its 14-ounce cans of Progresso Organic Chicken Noodle Soup are said to contain allergens including soy and dairy, which are not labeled on the can.
J&J strikes $6.5B deal for autoimmune disease specialist Momenta
The deal gives J&J's Janssen unit access to Momenta's experimental therapy, nipocalimab, being tested for myasthenia gravis, a neuromuscular disease that causes weakness in muscles, and other diseases where the immune system attacks the body.
Pope: rich can't get priority for vaccine, poor need help
Pope Francis on Wednesday it would be "sad" to prioritize giving a COVID-19 vaccines "to the richest" rather than the poor.
Australia announces free coronavirus vaccine deal
Australia has announced a deal to manufacture a potential coronavirus vaccine being developed by British-Swedish pharmaceutical company AstraZenec.
Bill Gates: If 30-60% of Americans take coronavirus vaccine, 'exponential spread' will stop
Bill Gates said Tuesday that if just 30-60 percent of the U.S. population get a coronavirus vaccine, that will be enough to slow the spread.
FDA warns of false coronavirus test results from Thermo Fisher kit
The Food and Drug Administration on Monday warned health care providers of false-positive coronavirus test results using the Thermo Fisher Scientific TaqPath COVID-19 Combo Kit.



















